Literature DB >> 8769647

V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.

C J Guidos1, C J Williams, I Grandal, G Knowles, M T Huang, J S Danska.   

Abstract

Double-stranded DNA breaks (DSBs) trigger p53-mediated cell cycle arrest or apoptosis pathways that limit the oncogenic consequences of exposure to genotoxic agents, but p53-mediated responses to DSB generated by normal physiologic events have not been documented. "Broken" V(D)J coding ends accumulate in scid lymphocyte precursors as a consequence of a mutation in DNA-dependent protein kinase (DNA-PK). The ensuing failure to rearrange efficiently antigen receptors arrests lymphoid development. Here we show that scid thymocytes express high levels of p53 protein, attributable to recombinase activating gene (RAG)-dependent generation of DSB adjacent to V, D, and J gene segments. To examine the functional importance of p53 expression in vivo, we bred p53-/- scid mice. The absence of p53 facilitated production of in-frame V(D)Jbeta coding joints and developmental progression of scid thymocytes, in addition to a dramatic accumulation of pro-B cells. All mice developed disseminated pro-B or immature T cell lymphoma/leukemia by 7-12 weeks of age. We present evidence that p53 deficiency prolongs the survival of scid lymphocyte precursors harboring broken V(D)J coding ends, allowing the accumulation of aneuploid cells. These results demonstrate that a p53-mediated DNA damage checkpoint contributes to the immune deficiency characteristic of the scid mutation and limits the oncogenic potential of DSBs generated during V(D)J recombination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769647     DOI: 10.1101/gad.10.16.2038

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  89 in total

Review 1.  Transposition mediated by RAG1 and RAG2 and the evolution of the adaptive immune system.

Authors:  D G Schatz
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The RAG proteins in V(D)J recombination: more than just a nuclease.

Authors:  M J Sadofsky
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

3.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest.

Authors:  S Wang; M Guo; H Ouyang; X Li; C Cordon-Cardo; A Kurimasa; D J Chen; Z Fuks; C C Ling; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 4.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 5.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

6.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

7.  NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development.

Authors:  Rosa Berga-Bolaños; Maria Alberdi; Maria Buxadé; José Aramburu; Cristina López-Rodríguez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.

Authors:  Isaac Engel; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

10.  PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

Authors:  Sung Hoon Cho; Shreevrat Goenka; Tiina Henttinen; Prathyusha Gudapati; Arja Reinikainen; Christine M Eischen; Riitta Lahesmaa; Mark Boothby
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.